Literature DB >> 25505243

Heart mitochondrial TTP synthesis and the compartmentalization of TMP.

Vasudeva G Kamath1, Chia-Heng Hsiung1, Zachary J Lizenby1, Edward E McKee2.   

Abstract

The primary pathway of TTP synthesis in the heart requires thymidine salvage by mitochondrial thymidine kinase 2 (TK2). However, the compartmentalization of this pathway and the transport of thymidine nucleotides are not well understood. We investigated the metabolism of [(3)H]thymidine or [(3)H]TMP as precursors of [(3)H]TTP in isolated intact or broken mitochondria from the rat heart. The results demonstrated that [(3)H]thymidine was readily metabolized by the mitochondrial salvage enzymes to TTP in intact mitochondria. The equivalent addition of [(3)H]TMP produced far less [(3)H]TTP than the amount observed with [(3)H]thymidine as the precursor. Using zidovudine to inhibit TK2, the synthesis of [(3)H]TTP from [(3)H]TMP was effectively blocked, demonstrating that synthesis of [(3)H]TTP from [(3)H]TMP arose solely from the dephosphorysynthase pathway that includes deoxyuridine triphosphatelation of [(3)H]TMP to [(3)H]thymidine. To determine the role of the membrane in TMP metabolism, mitochondrial membranes were disrupted by freezing and thawing. In broken mitochondria, [(3)H]thymidine was readily converted to [(3)H]TMP, but further phosphorylation was prevented even though the energy charge was well maintained by addition of oligomycin A, phosphocreatine, and creatine phosphokinase. The failure to synthesize TTP in broken mitochondria was not related to a loss of membrane potential or inhibition of the electron transport chain, as confirmed by addition of carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone and potassium cyanide, respectively, in intact mitochondria. In summary, these data, taken together, suggest that the thymidine salvage pathway is compartmentalized so that TMP kinase prefers TMP synthesized by TK2 over medium TMP and that this is disrupted in broken mitochondria.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Mitochondria; Mitochondrial Metabolism; Nucleoside/Nucleotide Biosynthesis; Nucleoside/Nucleotide Metabolism; Thymidine Kinase 2

Mesh:

Substances:

Year:  2014        PMID: 25505243      PMCID: PMC4303658          DOI: 10.1074/jbc.M114.624213

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Phosphorylation of thymidine and AZT in heart mitochondria: elucidation of a novel mechanism of AZT cardiotoxicity.

Authors:  Edward E McKee; Alice T Bentley; Matthew Hatch; Joel Gingerich; Delia Susan-Resiga
Journal:  Cardiovasc Toxicol       Date:  2004       Impact factor: 3.231

2.  Isolation and incubation conditions to study heart mitochondrial protein synthesis.

Authors:  E E McKee; B L Grier; G S Thompson; J D McCourt
Journal:  Am J Physiol       Date:  1990-03

Review 3.  The 5'-nucleotidases as regulators of nucleotide and drug metabolism.

Authors:  Sally Anne Hunsucker; Beverly S Mitchell; Jozef Spychala
Journal:  Pharmacol Ther       Date:  2005-07       Impact factor: 12.310

Review 4.  Deoxyribonucleotides as genetic and metabolic regulators.

Authors:  Christopher K Mathews
Journal:  FASEB J       Date:  2014-06-13       Impact factor: 5.191

5.  Control of thymidine kinase mRNA during the cell cycle.

Authors:  D L Coppock; A B Pardee
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

6.  Cloning and characterization of the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster.

Authors:  M Johansson; A R van Rompay; B Degrève; J Balzarini; A Karlsson
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

7.  A deoxyribonucleotidase in mitochondria: involvement in regulation of dNTP pools and possible link to genetic disease.

Authors:  C Rampazzo; L Gallinaro; E Milanesi; E Frigimelica; P Reichard; V Bianchi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

8.  Characterization of a dCTP transport activity reconstituted from human mitochondria.

Authors:  E G Bridges; Z Jiang; Y C Cheng
Journal:  J Biol Chem       Date:  1999-02-19       Impact factor: 5.157

9.  mtDNA depletion myopathy: elucidation of the tissue specificity in the mitochondrial thymidine kinase (TK2) deficiency.

Authors:  Ann Saada; Avraham Shaag; Orly Elpeleg
Journal:  Mol Genet Metab       Date:  2003-05       Impact factor: 4.797

Review 10.  Mammalian deoxyribonucleoside kinases.

Authors:  E S Arnér; S Eriksson
Journal:  Pharmacol Ther       Date:  1995       Impact factor: 12.310

View more
  5 in total

1.  Deoxycytidine and Deoxythymidine Treatment for Thymidine Kinase 2 Deficiency.

Authors:  Carlos Lopez-Gomez; Rebecca J Levy; Maria J Sanchez-Quintero; Martí Juanola-Falgarona; Emanuele Barca; Beatriz Garcia-Diaz; Saba Tadesse; Caterina Garone; Michio Hirano
Journal:  Ann Neurol       Date:  2017-05-04       Impact factor: 10.422

2.  [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity.

Authors:  Woosuk Kim; Thuc M Le; Liu Wei; Soumya Poddar; Jimmy Bazzy; Xuemeng Wang; Nhu T Uong; Evan R Abt; Joseph R Capri; Wayne R Austin; Juno S Van Valkenburgh; Dalton Steele; Raymond M Gipson; Roger Slavik; Anthony E Cabebe; Thotsophon Taechariyakul; Shahriar S Yaghoubi; Jason T Lee; Saman Sadeghi; Arnon Lavie; Kym F Faull; Owen N Witte; Timothy R Donahue; Michael E Phelps; Harvey R Herschman; Ken Herrmann; Johannes Czernin; Caius G Radu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

3.  Biochemical Characterizations of Human TMPK Mutations Identified in Patients with Severe Microcephaly: Single Amino Acid Substitutions Impair Dimerization and Abolish Their Catalytic Activity.

Authors:  Junmei Hu Frisk; Jo M Vanoevelen; Jörgen Bierau; Gunnar Pejler; Staffan Eriksson; Liya Wang
Journal:  ACS Omega       Date:  2021-12-06

Review 4.  Mitochondrial DNA Depletion Syndrome and Its Associated Cardiac Disease.

Authors:  Haiying Wang; Yijun Han; Shenwei Li; Yunan Chen; Yafen Chen; Jing Wang; Yuqing Zhang; Yawen Zhang; Jingsuo Wang; Yong Xia; Jinxiang Yuan
Journal:  Front Cardiovasc Med       Date:  2022-02-14

5.  Uridine Treatment of the First Known Case of SLC25A36 Deficiency.

Authors:  Luisa Jasper; Pasquale Scarcia; Stephan Rust; Janine Reunert; Ferdinando Palmieri; Thorsten Marquardt
Journal:  Int J Mol Sci       Date:  2021-09-14       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.